Therefore a lack of adjustment for these important risk factors in the age-sex-adjusted models (Table 2) would certainly lead to biased estimates showing a significantly higher risk of bladder cancer associated with insulin use. This evidence concerns the gene INS and urinary bladder carcinoma.